Menu
Currency
GWAS Study

Genome-wide association and functional interrogation identified a variant at 3p26.1 modulating ovarian cancer survival among Chinese women.

Dai H, Chu X, Liang Q et al.

34930913 PubMed ID
GWAS Study Type
2130 Participants
34 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

DH
Dai H
CX
Chu X
LQ
Liang Q
WM
Wang M
LL
Li L
ZY
Zhou Y
ZZ
Zheng Z
WW
Wang W
WZ
Wang Z
LH
Li H
WJ
Wang J
ZH
Zheng H
ZY
Zhao Y
LL
Liu L
YH
Yao H
LM
Luo M
WQ
Wang Q
KS
Kang S
LY
Li Y
WK
Wang K
SF
Song F
ZR
Zhang R
WX
Wu X
CX
Cheng X
ZW
Zhang W
WQ
Wei Q
LM
Li MJ
CK
Chen K
Chapter II

Abstract

Summary of the research findings

Ovarian cancer survival varies considerably among patients, to which germline variation may also contribute in addition to mutational signatures. To identify genetic markers modulating ovarian cancer outcome, we performed a genome-wide association study in 2130 Chinese ovarian cancer patients and found a hitherto unrecognized locus at 3p26.1 to be associated with the overall survival (Pcombined = 8.90 × 10-10). Subsequent statistical fine-mapping, functional annotation, and eQTL mapping prioritized a likely casual SNP rs9311399 in the non-coding regulatory region. Mechanistically, rs9311399 altered its enhancer activity through an allele-specific transcription factor binding and a long-range interaction with the promoter of a lncRNA BHLHE40-AS1. Deletion of the rs9311399-associated enhancer resulted in expression changes in several oncogenic signaling pathway genes and a decrease in tumor growth. Thus, we have identified a novel genetic locus that is associated with ovarian cancer survival possibly through a long-range gene regulation of oncogenic pathways.

1,346 Chinese ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

2130
Total Participants
GWAS
Study Type
Yes
Replicated
784 Chinese ancestry individuals
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.